Abstract
Influenza is a widespread disease caused by infection with the influenza virus. Vaccination is considered to be the main countermeasure against influenza. A split vaccine is widely used to avoid severe adverse events, and it induces strong humoral immunity. However, the split vaccine alone cannot elicit mucosal immunity, including IgA production, and its preventative effects are limited. Here, we show that the green tea cultivar ‘Benifuuki’ extract enhanced the effect of a split vaccine on mucosal immunity. The frequency of IgA+ cells was increased in lung and Peyer’s patch that received Benifuuki diet. Secretion of hemagglutinin-specific mucosal IgA, which is closely linked to the prevention of viral infection, was significantly increased in the bronchoalveolar lavage fluid of split vaccine-immunized BALB/c mice that were administered green tea Benifuuki extract. Our findings suggest that Benifuuki intake enhanced the effects of the split vaccine on mucosal immunity.
Similar content being viewed by others
References
Centers for Disease Control and Prevention (CDC) (2010) Estimates of deaths associated with seasonal influenza—United States, 1976–2007. MMWR Morb Mortal Wkly Rep 59:1057–1062
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179–186
Koyama S, Aoshi T, Tanimoto T, Kumagai Y, Kobiyama K, Tougan T, Sakurai K, Coban C, Horii T, Akira S, Ishii KJ (2010) Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2:25ra24
Wong SS, Webby RJ (2013) Traditional and new influenza vaccines. Clin Microbiol Rev 26:476–492
Chen D, Periwal SB, Larrivee K, Zuleger C, Erickson CA, Endres RL, Payne LG (2001) Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J Virol 75:7956–7965
Mantis NJ, Rol N, Corthésy B (2011) Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603–611
Proudfoot O, Esparon S, Tang CK, Laurie K, Barr I, Pietersz G (2015) Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung. BMC Infect Dis 15:101
Le TV, Mironova E, Garcin D, Compans RW (2011) Induction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus. PLoS One 6:e18780
Fagarasan S, Honjo T (2003) Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3:63–72
Dougan SK, Ashour J, Karssemeijer RA, Popp MW, Avalos AM, Barisa M, Altenburg AF, Ingram JR, Cragnolini JJ, Guo C, Alt FW, Jaenisch R, Ploegh HL (2013) Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus. Nature 503:406–409
Imai K, Suga K, Nakachi K (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26:769–775
Baba Y, Sonoda JI, Hayashi S, Tosuji N, Sonoda S, Makisumi K, Nakajo M (2012) Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med 4:452–458
Stoicov C, Saffari R, Houghton J (2009) Green tea inhibits Helicobacter growth in vivo and in vitro. Int J Antimicrob Agents 33:473–478
Kim YJ, Houng SJ, Kim JH, Kim YR, Ji HG, Lee SJ (2012) Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL/6 mice. J Nutr Biochem 23:186–191
Yung LM, Leung FP, Wong WT, Tian XY, Yung LH, Chen ZY, Yao XQ, Huang Y (2008) Tea polyphenols benefit vascular function. Inflammopharmacology 16:230–234
Hotta Y, Huang L, Muto T, Yajima M, Miyazeki K, Ishikawa N, Fukuzawa Y, Wakida Y, Tushima H, Ando H, Nonogaki T (2006) Positive inotropic effect of purified green tea catechin derivative in guinea pig hearts: the measurements of cellular Ca2+ and nitric oxide release. Eur J Pharmacol 552:123–130
Marathe SA, Datey AA, Chakravortty D (2012) Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases. Recent Pat Antiinfect Drug Discov 7:123–132
Tsukamoto S, Huang Y, Umeda D, Yamada S, Yamashita S, Kumazoe M, Kim Y, Murata M, Yamada K, Tachibana H (2014) 67-kDa laminin receptor-dependent protein phosphatase 2A (PP2A) activation elicits melanoma-specific antitumor activity overcoming drug resistance. J Bio Chem 289:32671–32681
Suzuki T, Kumazoe M, Kim Y, Yamashita S, Nakahara K, Tsukamoto S, Sasaki M, Hagihara T, Tsurudome Y, Huang Y, Maeda-Yamamoto M, Shinoda Y, Yamaguchi W, Yamada K, Tachibana H (2013) Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorder. Sci Rep 3:2749
Yoshino K, Miyase T, Sano M (2010) Preventive effects of C-2 epimeric isomers of tea catechins on mouse type I allergy. J Nutr Sci Vitaminol (Tokyo) 56:211–215
Persson IA, Josefsson M, Persson K, Andersson RG (2006) Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 58:1139–1144
Maeda-Yamamoto M, Ema K, Tokuda Y, Monobe M, Tachibana H, Sameshima Y, Kuriyama S (2011) Effect of green tea powder (Camellia sinensis L. cv. Benifuuki) particle size on O-methylated EGCG absorption in rats; The Kakegawa Study. Cytotechnology 63:171–179
Maeda-Yamamoto M, Ema K, Monobe M, Tokuda Y, Tachibana H (2012) Epicatechin-3-O-(3″-O-methyl)-gallate content in various tea cultivars (Camellia sinensis L.) and its in vitro inhibitory effect on histamine release. J Agric Food Chem 60:2165–2170
Kurita I, Maeda-Yamamoto M, Tachibana H, Kamei M (2010) Antihypertensive effect of Benifuuki tea containing O-methylated EGCG. J Agric Food Chem 58:1903–1908
Maeda-Yamamoto M, Ema K, Shibuichi I (2007) In vitro and in vivo anti-allergic effects of ‘benifuuki’ green tea containing O-methylated catechin and ginger extract enhancement. Cytotechnology 55:135–142
Maeda-Yamamoto M, Ema K, Monobe M, Shibuichi I, Shinoda Y, Yamamoto T, Fujisawa T (2009) The efficacy of early treatment of seasonal allergic rhinitis with benifuuki green tea containing O-methylated catechin before pollen exposure: an open randomized study. Allergol Int 58:437–444
Albu DI, Jones-Trower A, Woron AM, Stellrecht K, Broder CC, Metzger DW (2003) Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. J Virol 77:5589–5597
van Riet E, Ainai A, Suzuki T, Hasegawa H (2012) Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine 30:5893–5900
Cao W, Liu YJ (2007) Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 19:24–30
Stöhr K (2002) Influenza—WHO cares. Lancet Infect Dis 2:517
Nichol KL, Treanor JJ (2006) Vaccines for seasonal and pandemic influenza. J Infect Dis 194:S111–S118
Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340–346
Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT; HIV Outpatient Study (HOPS) Investigators (2015) Seasonal influenza vaccination rates in the HIV outpatient study—United States, 1999–2013. Clin Infect Dis 60:976–977
Weber C, Sliva K, von Rhein C, Kümmerer BM, Schnierle BS (2015) The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antiviral Res 113:1–3
Huang HC, Tao MH, Hung TM, Chen JC, Lin ZJ, Huang C (2014) (−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antiviral Res 111:100–111
Ahmed M, Henson DA, Sanderson MC, Nieman DC, Gillitt ND, Lila MA (2014) The protective effects of a polyphenol-enriched protein powder on exercise-induced susceptibility to virus infection. Phytother Res 28:1829–1836
Pang JY, Zhao KJ, Wang JB, Ma ZJ, Xiao XH (2014) Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. J Zhejiang Univ Sci B 15:533–539
Kim M, Kim SY, Lee HW, Shin JS, Kim P, Jung YS, Jeong HS, Hyun JK, Lee CK (2013) Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate. Antiviral Res 100:460–472
Suzuki Y (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 28:399–408
Kuno-Sakai H, Kimura M, Ohta K, Shimojima R, Oh Y, Fukumi H (1994) Developments in mucosal influenza virus vaccines. Vaccine 12:1303–1310
Sawaengsak C, Mori Y, Yamanishi K, Mitrevej A, Sinchaipanid N (2014) Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine. AAPS PharmSciTech 15:317–325
de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K (2012) Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. Vaccine 30:4884–4891
Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206:79–87
Acknowledgments
This work was kindly supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science to H. Tachibana (Grant Numbers 22228002 and 15H02448).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Electronic supplementary material
Below are the links to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Won, YS., Kumazoe, M., Takamatsu, K. et al. Green tea cultivar ‘Benifuuki’ potentiates split vaccine-induced immunoglobulin A production. J Nat Med 71, 68–75 (2017). https://doi.org/10.1007/s11418-016-1028-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-016-1028-7